Amphion Innovations

Amphion Innovations

Amphion Innovations is a principal investment firm specializing in early-stage medical, life sciences, and technology companies.

Amphion Innovations is a venture capital investment firm which specializes in seed, early-stage and later-stage investments. The firm prefers to invest in companies based in the United States and United Kingdom operating in the medical and technology sectors. It was incorporated in 1984 and is based in New York City.

Amphion Innovations does not invest in companies with technologies requiring long development timelines or excessive capital investment. They prefer investments in the medical, life sciences, and technology sectors with defensible core intellectual property, management experience and growth potential in markets of at least $1 billion in size together with corporations, governments, universities, and entrepreneurs.

The firm typically invests in companies with broad-based, proprietary, platform technologies in the areas of pharmacogenomics, proteomics, nutriceuticals or wellness, diagnostics, medical products and related fields, leveraging advances in and the convergence of materials science and life science IT, particularly software technologies. It targets investments in companies based in both the United States and United Kingdom.

Amphion Innovations makes investments in companies requiring capital of up to $5 million in the first one to two years, with additional capital requirements of between $15 million and $25 million and at least $1 billion in size. They act as a lead investor and seek to acquire a sizable ownership stake and measure of influence or control in their portfolio companies. The firm makes investments in the form of preferred stock or convertible debt or leverages through the ownership of stock warrants and stock options.

Timeline

Funded Companies

Company
Description
Website
Industry
Location
WellGen

A biotechnology company developing plant-based wellness products with the use of nutrigenomics

Biotechnology
Philadelphia
Motif BioSciences

A biopharmaceutical company developing antibiotics for infections from multi-drug resistant bacteria

Biotechnology
New York City
Kromek

3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Raymond P. McKenzie

Senior Advisor

Richard C. E. Morgan

CEO

Robert J. Bertoldi

President and Chief Financial Officer

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.